FrancophonIA/ELRC3.0 huggingface dataset:
English: • nerve root compression (including low back pain and leg pain);
Danish: • nerverodskompression (inklusive smerter i den nederste del af ryggen og bensmerter),
English: The number of all cause hospitalisations in the adalimumab treatment group was 0.18 per patient year versus 0.26 per patient year in the placebo group and the corresponding figures for UC-related hospitalisations were 0.12 per patient year versus 0.22 per patient year.
Danish: I løbet af 52 uger i studierne UC-I og UC-II blev der observeret lavere forekomst af indlæggelser forårsaget af enhver årsag samt UC-relaterede indlæggelser i adalimumab-behandlingsarmen sammenlignet med placebo-armen.Antallet af indlæggelser forårsaget af enhver årsag var 0,18 pr. patientår versus 0,26 pr. patientår i placebogruppen, og de tilsvarende tal for UC-relaterede indlæggelser var 0,12 pr. patientår versus 0,22 pr. patientår.
English: Pack size of one pre-filled syringe.
Danish: Pakningsstørrelser med én fyldt injektionssprøjte.
English: In Period A, patients received placebo or adalimumab at an initial dose of 160 mg at week 0 and 80 mg at week 2 and 40 mg every week starting at week 4 to week 11.
Danish: I periode A fik patienterne placebo eller adalimumab i en startdosis på 160 mg i uge 0 og 80 mg i uge 2 og 40 mg hver uge fra uge 4 til uge 11.
English: Step 2: Get ready E. Pull the needle cap straight out and away from your body when you are ready to inject.
Danish: E. Træk kanylehætten lige af og væk fra kroppen, når du er klar til at give injektionen.
English: ● Do not remove the needle cap from the syringe until you are ready to inject.
Danish: ● Tag ikke kanylehætten af injektionssprøjten, før du er klar til at give injektionen.
English: • sleep interruptions;
Danish: • søvnafbrydelser,
English: AMGEVITA is administered via subcutaneous injection.
Danish: AMGEVITA administeres ved subkutan injektion.
English: Induction Dose
Danish: Induktionsdosis
English: AMGEVITA is administered by subcutaneous injection.
Danish: AMGEVITA administreres som subkutan injektion.
English: Use a new AMGEVITA pre-filled syringe.
Danish: Brug en ny AMGEVITA fyldt injektionssprøjte.
English: Label expiration date
Danish: Etiket med udløbsdato
English: All subjects received open-label induction therapy at a dose based on their baseline body weight: 160 mg at week 0 and 80 mg at week 2 for subjects ≥ 40 kg, and 80 mg and 40 mg, respectively, for subjects < 40 kg.
Danish: Alle patienter fik åben induktionsbehandling med doser baseret på deres baseline-legemsvægt: henholdsvis 160 mg i uge 0 og 80 mg i uge 2 til patienter ≥ 40 kg og 80 mg henh.
English: In study UC-II, 248 patients received 160 mg of adalimumab at week 0, 80 mg at week 2 and 40 mg every other week thereafter, and 246 patients received placebo.
Danish: I studie UC-II fik 248 patienter 160 mg adalimumab i uge 0, 80 mg i uge 2 og derefter 40 mg hver anden uge.
English: Efficacy Response in Placebo-Controlled Period for Study nr-axSpA II
Danish: Effekt respons i den placebokontrollerede periode af Studie nr-axSpA II Dobbelt-blind respons ved uge 68
English: ● Do not reuse the pre-filled pen.
Danish: ● Den fyldte pen må ikke genbruges.
English: OTHER SPECIAL WARNING(S), IF NECESSARY Contains latex, read the package leaflet before use.
Danish: EVENTUELLE ANDRE SÆRLIGE ADVARSLER Indeholder latex.
English: • erythema multiforme (inflammatory skin rash);
Danish: • betændelseslignede hududslæt (erythema multiforme),
English: • gallbladder inflammation, gallbladder stones;
Danish: • inflammation i galdeblæren, galdesten,
English: The mean steady-state trough concentration at week 12 through week 36 were approximately 8 to 10 μg/mL during adalimumab 40 mg every week treatment.
Danish: Den gennemsnitlige dal-koncentration ved steady state var ca. 8 til 10 μg/ml under behandling med adalimumab 40 mg hver uge fra uge 12 frem til og med uge 36.
English: AMGEVITA 40 mg solution for injection in pre-filled pen 0.8 mL solution for injection in pre-filled pen for patient use containing a pre-filled syringe (type I glass).
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt pen 0,8 ml opløsning, injektionsvæske, i fyldt pen, der bruges af patienten selv, med en fyldt injektionssprøjte (type 1-glas).
English: • breaking of finger nails and toe nails;
Danish: • fingernegle og tånegle knækker,
English: AMGEVITA 40 mg solution for injection in pre-filled pen adalimumab
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt pen adalimumab
English: ● Do not grasp the plunger rod.
Danish: ● Tag ikke fat i stempelstangen.
English: Important: Always hold the pre-filled syringe by the syringe barrel.
Danish: Vigtigt: Hold altid på den fyldte injektionssprøjte ved at tage fat i sprøjtehuset.
English: In Period A, patients received placebo or adalimumab at an initial dose of 160 mg at week 0, 80 mg at week 2, and 40 mg every week starting at week 4 to week 11.
Danish: I periode A fik patienterne placebo eller adalimumab i en startdosis på 160 mg i uge 0, 80 mg i uge 2 og 40 mg hver uge fra uge 4 til uge 11.
English: The usual dose for adults with non-infectious uveitis is an initial dose of 80 mg (as two 40 mg injections in one day), followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den normale dosis for voksne med ikke-infektiøs uveitis er en startdosis på 80 mg (som to 40 mg injektioner på én dag) efterfulgt af 40 mg hver anden uge med start en uge efter den første dosis.
English: The safety and efficacy of adalimumab were also studied in adult patients with moderate to severe chronic plaque psoriasis with concomitant hand and/or foot psoriasis who were candidates for systemic therapy in a randomised double-blind study (psoriasis study III).
Danish: Adalimumabs sikkerhed og virkning er også blevet undersøgt i et randomiseret dobbelt-blindet studie (Psoriasis-studie III) med voksne patienter med moderat til svær kronisk plaque-psoriasis og samtidig psoriasis på hænder og/eller fødder, som var kandidater til systemisk behandling.
English: AMGEVITA 40 mg solution for injection in pre-filled syringe 0.8 mL solution in pre-filled syringe (type I glass) with a plunger stopper (bromobutyl rubber) and a stainless steel needle with a needle shield (thermoplastic elastomer).
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte 0,8 ml opløsning i fyldt injektionssprøjte (type 1-glas) med stempelprop (brombutylgummi) og kanyle af rustfrit stål med beskyttelseshætte (termoplastisk elastomer).
English: AMGEVITA 20 mg solution for injection in pre-filled syringe AMGEVITA 40 mg solution for injection in pre-filled syringe adalimumab
Danish: AMGEVITA 20 mg injektionsvæske, opløsning i fyldt injektionssprøjte AMGEVITA 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte adalimumab
English: Discontinuation of AMGEVITA therapy should be considered in patients with confirmed significant haematologic abnormalities.
Danish: Hos patienter med bekræftede signifikante hæmatologiske abnormiteter bør det overvejes at afbryde behandlingen med AMGEVITA.
English: In these trials, 11.9% of patients treated with adalimumab and 8.1% of placebo and active control-treated patients that had negative baseline anti-nuclear antibody titres reported positive titres at week 24.
Danish: Patienter fik testet serumprøver for autoantistoffer på forskellige tidspunkter i reumatoid artrit-studie I-V. I disse havde 11,9 % af de adalimumab-behandlede patienter og 8,1 % af de placebo-og aktiv kontrolbehandlede patienter med negative antinukleære antistoftitere ved baseline positive titere efter 24 uger.
English: AMGEVITA 20 mg solution for injection in pre-filled syringe 0.4 mL solution in pre-filled syringe (type I glass) with a plunger stopper (bromobutyl rubber) and a stainless steel needle with a needle shield (thermoplastic elastomer).
Danish: AMGEVITA 20 mg injektionsvæske, opløsning i fyldt injektionssprøjte 0,4 ml opløsning i fyldt injektionssprøjte (type 1-glas) med stempelprop (brombutylgummi) og kanyle af rustfrit stål med beskyttelseshætte (termoplastisk elastomer).
English: Polyarticular juvenile idiopathic arthritis from 2 years of age The recommended dose of AMGEVITA for patients with polyarticular juvenile idiopathic arthritis, from 2 years of age is based on body weight (table 1).
Danish: Den anbefalede AMGEVITA-dosis til patienter fra 2 år med polyartikulær juvenil idiopatisk artrit er baseret på legemsvægt (tabel 1).
English: The recommended dose of AMGEVITA for patients with enthesitis-related arthritis from 6 years of age is based on body weight (table 2).
Danish: Den anbefalede AMGEVITA-dosis til patienter med entesopatirelateret artrit fra 6 år er baseret på legemsvægt (tabel 2).
English: How to use AMGEVITA
Danish: Sådan skal du tage AMGEVITA
English: Adalimumab 40 mg eow N = 814 n (%)
Danish: Adalimumab 40 mg hveranden uge N = 814 n (%)
English: Yellow cap on
Danish: Gul hætte på
English: • urinary tract infection;
Danish: • urinvejsinfektion,
English: • rash;
Danish: • rysten,
English: AMGEVITA is used to treat psoriatic arthritis in adults.
Danish: AMGEVITA bruges til at behandle psoriasisartrit hos voksne.
English: Ophthalmologists are advised to consult with an appropriate specialist before initiation of treatment with AMGEVITA (see section 4.4).
Danish: Før initiering af behandling med AMGEVITA rådes øjenlæger til at rådføre sig med en passende specialist (se pkt.
English: Children and adolescents from 4 to 17 years of age weighing 30 kg or more The recommended dose of AMGEVITA is an initial dose of 40 mg, followed by 40 mg one week later.
Danish: Børn og unge fra 4 til 17 år, der vejer 30 kg eller derover Den anbefalede dosis AMGEVITA er en startdosis på 40 mg efterfulgt af 40 mg en uge senere.
English: Coagulation and bleeding disorders (including activated partial thromboplastin time prolonged), Autoantibody test positive (including double stranded DNA antibody),
Danish: Forstyrrelser i koagulationssystemet og af blødning (inklusive forlænget aktiveret partiel tromboplastintid),
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON PRE-FILLED PEN
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON MED FYLDT PEN
English: AMGEVITA 40 mg solution for injection in pre-filled pen Each single dose pre-filled pen contains 40 mg of adalimumab in 0.8 mL (50 mg/mL) solution.
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt pen Hver fyldte enkeltdosis pen indeholder 40 mg adalimumab i 0,8 ml (50 mg/ml) opløsning.
English: Used syringe barrel
Danish: Brugt kanyle
English: On the basis of clinical trial data in patients with JIA (pJIA and ERA), an exposure-response relationship was established between plasma concentrations and PedACR 50 response.
Danish: Der er fundet en eksponerings-respons sammenhæng mellem plasmakoncentration og PedACR 50-respons på basis af data fra kliniske studier i patienter med JIA (pJIA og ERA).
English: Phase
Danish: Endepunkt
English: If a faster response is required, your doctor may prescribe an initial dose of 160 mg (as four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), followed by 80 mg (as two 40 mg injections in one day) two weeks later, and thereafter as 40 mg every other week.
Danish: Hvis et hurtigere respons er nødvendigt, kan din læge ordinere en startdosis på 160 mg (som fire 40 mg-injektioner på en dag eller to 40 mg-injektioner pr. dag i to på hinanden følgende dage), efterfulgt af 80 mg (som to 40 mg injektioner om dagen) 2 uger senere, og derefter 40 mg hver anden uge.
English: A loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 μg/mL during the induction period.
Danish: Ved en induktionsdosis på 160 mg adalimumab i uge 0 efterfulgt af 80 mg adalimumab i uge 2 blev opnået dal-serum-koncentrationer af adalimumab på ca. 12 µg/ml i induktionsperioden.
English: AMGEVITA 20 mg solution for injection in pre-filled syringe AMGEVITA 40 mg solution for injection in pre-filled syringe Solution for injection (injection).
Danish: AMGEVITA 20 mg injektionsvæske, opløsning i fyldt injektionssprøjte AMGEVITA 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte Injektionsvæske, opløsning (injektionsvæske).
English: AMGEVITA 40 mg solution for injection in pre-filled pen.
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt pen.
English: Kύπρος
Danish: Κύπρος
English: Urinary tract infections (including pyelonephritis), Fungal infections,
Danish: Infektioner i reproduktionsvejene (inklusive vulvovaginal svampeinfektion), Urinvejsinfektioner (inklusive pylonephritis), Svampeinfektioner,
English: Some patients who experience decrease in their response to AMGEVITA 40 mg every other week may benefit from an increase in dosage to 40 mg AMGEVITA every week or 80 mg every other week.
Danish: Nogle patienter, som oplever, at deres respons på AMGEVITA 40 mg hver anden uge bliver dårligere, kan have fordel af at øge dosis til 40 mg AMGEVITA hver uge eller 80 mg hver anden uge.
English: The usual dose regimen for Crohn's disease is 80 mg (as two 40 mg injections in one day) initially followed by 40 mg every other week two weeks later.
Danish: Startdosis for Crohns sygdom er sædvanligvis 80 mg (som to 40 mg injektioner om dagen) efterfulgt af 40 mg hver anden uge 2 uger senere.
English: The recommended AMGEVITA induction dose regimen for adult patients with moderate to severe ulcerative colitis is 160 mg at week 0 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days) and 80 mg at week 2 (given as two 40 mg injections in one day).
Danish: Det anbefalede AMGEVITA dosis-induktionsregime til voksne patienter med moderat til svær colitis ulcerosa er 160 mg i uge 0 (givet som fire 40 mg injektioner på en dag eller som to 40 mg injektioner pr. dag i to på hinanden følgende dage) og 80 mg i uge 2 (givet som to 40 mg injektioner på en dag).
English: • low blood measurements for white blood cells;
Danish: • nedsat antal af hvide blodlegemer,
English: Visual impairment, Conjunctivitis, Blepharitis, Eye swelling
Danish: Synsforstyrrelser, Konjunktivitis, Blepharitis,
English: The usual dose regimen is 80 mg (as two 40 mg injections in one day) initially followed by 40 mg two weeks later.
Danish: Den sædvanlige startdosis er 80 mg (som to 40 mg injektioner om dagen) efterfulgt af 40 mg to uger senere.
English: There is no relevant use of AMGEVITA in children aged less than 12 years in this indication.
Danish: Det er ikke relevant at bruge AMGEVITA hos børn under 12 år til denne indikation.
English: Used plunger rod Finger flange
Danish: Brugt stempelstang Fingergreb
English: Depending on your response, your doctor may increase the dosage to 40 mg every week or 80 mg every other week.
Danish: Afhængigt af dit respons, kan din læge forøge dosis til 40 mg hver uge eller 80 mg hver anden uge.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK CARTON PRE-FILLED PEN (with blue box)
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE MULTIPAKNING KARTON MED FYLDT PEN (med blå boks)
English: The combination of AMGEVITA and abatacept is not recommended (see section 4.4 “Concurrent administration of biologic DMARDS or TNF-antagonists”).
Danish: 4.4 “Samtidig administration af biologiske DMARDs eller TNF-antagonister”).
English: In patients with ulcerative colitis, a loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 μg/mL during the induction period.
Danish: Hos patienter med colitis ulcerosa gav en startdosis på 160 mg adalimumab i uge 0 efterfulgt af 80 mg adalimumab i uge 2 dal-serumkoncentrationer af adalimumab på omkring 12 µg/ml i induktionsperioden.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Danish: Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu og på Lægemiddelstyrelsens hjemmeside http://www.dkma.dk.
English: AMGEVITA single use pre-filled syringe For subcutaneous use
Danish: AMGEVITA fyldt injektionssprøjte til engangsbrug Til subkutan anvendelse
English: If a faster response is required, your doctor may prescribe an initial dose of 80 mg (as two 40 mg injections in one day) followed by 40 mg two weeks later.
Danish: Hvis hurtigere behandlingsrespons er nødvendigt, kan dit barns læge ordinere en startdosis på 80 mg (som to 40 mg-injektioner på en dag) efterfulgt af 40 mg to uger senere.
English: • kidney problems;
Danish: • nyreproblemer,
English: • pulmonary embolism (blockage in an artery of the lung);
Danish: • lungefibrose (dannelse af arvæv i lungerne),
English: With the yellow cap off, place the pre-filled pen on your skin at 90 degrees.
Danish: Anbring den fyldte pen på huden med en vinkel på 45 til 90 grader, mens den gule hætte er taget af.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON PRE-FILLED PEN (without blue box)
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON MED FYLDT PEN (uden blå boks)
English: Children and adolescents from 6 to 17 years of age weighing 40 kg or more
Danish: Børn og unge fra 6 til 17 år, som vejer 40 kg eller derover:
English: Always hold the syringe by the syringe barrel.
Danish: Hold altid på injektionssprøjten ved at tage fat i sprøjtehuset.
English: GI haemorrhage, Dyspepsia,
Danish: • snurren og prikken,
English: What AMGEVITA looks like and contents of the pack
Danish: Udseende og pakningsstørrelser
English: • intestinal perforation;
Danish: • perforering af tarmen,
English: The recommended AMGEVITA dose is 80 mg at Week 0 followed by 40 mg every other week starting at Week 1 via subcutaneous injection.
Danish: Den anbefalede AMGEVITA-dosis er 80 mg subkutant i uge 0, efterfulgt af 40 mg subkutant hver anden uge med start 1 uge efter den første dosis.
English: In monotherapy, some patients who experience a decrease in their response to AMGEVITA 40 mg every other week may benefit from an increase in dosage to 40 mg adalimumab every week or 80 mg every other week.
Danish: Ved behandling med AMGEVITA alene kan det være en fordel for visse patienter, der oplever faldende respons på AMGEVITA 40 mg hver anden uge, at øge dosis til 40 mg adalimumab hver uge eller 80 mg hver anden uge.
English: Renal impairment, Haematuria
Danish: Nyrer og urinveje
English: Clinical remission Clinical response (CR-100) Patients in steroid-free remission for > = 90 daysa * p < 0.001 for adalimumab versus placebo pairwise comparisons of proportions ** p < 0.02 for adalimumab versus placebo pairwise comparisons of proportions a Of those receiving corticosteroids at baseline
Danish: * p < 0,001 for adalimumab vs. placebo parvise sammenligninger af andelene ** p < 0,02 for adalimumab vs. placebo parvise sammenligninger af andelene a Af dem som fik kortikosteroider ved baseline
English: The usual dose for adults with plaque psoriasis is an initial dose of 80 mg (as two 40 mg injections in one day), followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den anbefalede dosis til voksne med plaque-psoriasis er en startdosis på 80 mg (som to 40 mg injektioner om dagen), efterfulgt af 40 mg hver anden uge startende en uge efter den første dosis.
English: Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of AMGEVITA is 40 mg every other week.
Danish: Børn, unge og voksne fra 2 år, der vejer 30 kg eller derover Den anbefalede dosis AMGEVITA er 40 mg hver anden uge.
English: The recommended dose of AMGEVITA for adult patients with uveitis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den anbefalede AMGEVITA-dosis til voksne patienter med uveitis er en startdosis på 80 mg efterfulgt af 40 mg hveranden uge med start en uge efter den første dosis.
English: AMGEVITA Dose for Paediatric Patients with Uveitis Patient Weight
Danish: AMGEVITA-dosis til pædiatriske patienter med uveitis Patient vægt
English: Children, adolescents and adults with polyarticular juvenile idiopathic arthritis Children and adolescents from 2 years of age weighing 10 kg to less than 30 kg The recommended dose of AMGEVITA is 20 mg every other week.
Danish: Børn, unge og voksne med polyartikulær juvenil idiopatisk artrit Børn og unge fra 2 år, der vejer fra 10 kg op til 30 kg Den anbefalede dosis AMGEVITA er 20 mg hver anden uge.
English: Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of AMGEVITA is 40 mg every other week.
Danish: Børn, unge og voksne fra 6 år, der vejer 30 kg eller derover Den anbefalede dosis AMGEVITA er 40 mg hver anden uge.
English: • headache;
Danish: • hårtab,
English: The recommended AMGEVITA dose regimen for adult patients with hidradenitis suppurativa (HS) is 160 mg initially at day 1 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days), followed by 80 mg two weeks later at day 15 (given as two 40 mg injections in one day).
Danish: Det anbefalede AMGEVITA dosisregime til voksne patienter med hidrosadenitis suppurativa (HS) er 160 mg på dag 1 (givet som fire injektioner af 40 mg på en dag eller som to injektioner af 40 mg pr. dag i to på hinanden følgende dage), efterfulgt af 80 mg to uger senere på dag 15 (givet som to injektioner af 40 mg på en dag).
English: AMGEVITA 40 mg solution for injection in pre-filled syringe Each single dose pre-filled syringe contains 40 mg of adalimumab in 0.8 mL (50 mg/mL) solution.
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldte enkeltdosis injektionssprøjte indeholder 40 mg adalimumab i 0,8 ml (50 mg/ml) opløsning.
English: Placebo/MTXadalimumab /MTX (95% confidence intervalb)
Danish: Placebo/MTXadalimumab/MTX
English: Children, adolescents and adults with enthesitis-related arthritis Children and adolescents from 6 years of age weighing 15 kg to less than 30 kg The recommended dose of AMGEVITA is 20 mg every other week.
Danish: Børn, unge og voksne med entesopati-relateret artrit Børn og unge fra 6 år, der vejer fra 15 kg op til 30 kg Den anbefalede dosis AMGEVITA er 20 mg hver anden uge.
English: ACR 70 6 months 12 months
Danish: ACR 70 Uge 12 Uge 24
English: If you use more AMGEVITA than you should
Danish: Hvis du har taget for meget AMGEVITA
English: Children, adolescents and adults with polyarticular juvenile idiopathic arthritis Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of AMGEVITA is 40 mg every other week.
Danish: Børn, unge og voksne med polyartikulær juvenil idiopatisk artrit Børn, unge og voksne fra 2 år, der vejer 30 kg eller derover Den anbefalede dosis AMGEVITA er 40 mg hver anden uge.
English: Children, adolescents and adults with enthesitis-related arthritis Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of AMGEVITA is 40 mg every other week.
Danish: Børn, unge og voksne med entesopati-relateret artrit Børn, unge og voksne fra 6 år, der vejer 30 kg eller derover Den anbefalede dosis AMGEVITA er 40 mg hver anden uge.
English: Before you use an AMGEVITA pre-filled syringe, read this important information:
Danish: Læs disse vigtige oplysninger, inden du bruger en AMGEVITA fyldt injektionssprøjte:
English: • abnormal muscle breakdown;
Danish: • unormale muskelssvigt,
English: When you are ready to inject, press the blue start button.
Danish: Tryk på den blå startknap, når du er klar til at injicere.
English: AMGEVITA 40 mg solution for injection in pre-filled syringe.
Danish: AMGEVITA 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte.
English: • scar;
Danish: • kløe,
English: Paediatric plaque psoriasis efficacy results at 16 weeks
Danish: Pædiatrisk ACR 30respons (n/N) Resultater af effekt Dobbeltblindet 32 uger
English: Reproductive tract infections (including vulvovaginal mycotic infection),
Danish: Intestinale infektioner (inklusive viral gastroenteritis),